Currently, there isn't any way of certainly concluding that a person is a carrier of this disease aside from DNA sequencing. However, one can conclude that an individual is a carrier when he/she has produced symptomatic offspring. However, mutations can also arise spontaneously, such as during recombination. Therefore, if ever I would include the parents of symptomatic individuals in my sampling population, there is no certainty that they have a mutation at all, which will be a waste of resources. The objective is to determine the frequency and prevalence of certain mutations (and not determine if there is a mutation at all) with the goal of using these certain mutations in making a diagnostic kit or carrier test panels. Should I just sample from a pool of symptomatic patients? Or should I look for carriers as well?

More Mark Girasol's questions See All
Similar questions and discussions